Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

162
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
162
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

165
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
165
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

176
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
176
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

382
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
382
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

68
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
68
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

469
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
469

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A morphometric characterization of early CHICK embryo elongation.

Developmental biology·2026
Same author

Bothrops jararacussu snake venom decreases CD1d, CD83, and CD86 expression on bone marrow-derived dendritic cells.

Immunology letters·2023
Same author

Unresectable stage III non-small cell lung cancer: Insights from a Portuguese expert panel.

Pulmonology·2023
Same author

Bothrops erythromelas venom and its action on isolated murine macrophages.

Toxicon : official journal of the International Society on Toxinology·2020
Same author

Extreme events are more likely to affect the breeding success of lesser kestrels than average climate change.

Scientific reports·2020
Same author

Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC).

Pulmonology·2019

Related Experiment Video

Updated: Nov 26, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.7K

Refractory Anemia in a Kidney Transplant Recipient.

I Duarte1, J Gameiro1, C Outerelo1

  • 1Division of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.

International Journal of Organ Transplantation Medicine
|December 14, 2020
PubMed
Summary
This summary is machine-generated.

Human parvovirus B19 (PVB19) infection can cause severe anemia in kidney transplant recipients. Reducing immunosuppression and administering immunoglobulin effectively treated this complication, restoring hemoglobin levels.

Keywords:
Kidney transplantParvovirus B19 infectionRefractory anemia

More Related Videos

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.3K
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

16.5K

Related Experiment Videos

Last Updated: Nov 26, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.7K
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.3K
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

16.5K

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Hematology

Background:

  • Anemia is a frequent complication following kidney transplantation (KT).
  • Post-transplant immunosuppression aims to prevent organ rejection but can increase infection susceptibility.

Observation:

  • A 34-year-old male kidney transplant recipient developed progressive dyspnea and fatigue one year post-transplant.
  • Laboratory findings revealed hypochromic microcytic anemia unresponsive to erythropoiesis-stimulating agents.
  • Bone marrow biopsy showed erythroid hyperplasia, and serological tests confirmed active human parvovirus B19 (PVB19) infection.

Findings:

  • The patient's anemia was attributed to PVB19 infection, a rare but significant post-transplant complication.
  • Treatment involved reducing immunosuppressive therapy and administering intravenous immunoglobulin.
  • Anemia resolved within one week, with sustained hemoglobin levels at two months.

Implications:

  • PVB19 infection should be considered in the differential diagnosis of anemia in kidney transplant patients.
  • Prompt diagnosis and management, including immunosuppression adjustment and immunoglobulin therapy, are crucial for recovery.
  • This case highlights the importance of monitoring for opportunistic infections in immunosuppressed transplant recipients.